Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1957 3
1958 2
1962 1
1963 2
1964 3
1965 2
1966 6
1967 5
1968 1
1969 9
1970 6
1971 13
1972 15
1973 9
1974 7
1975 8
1976 7
1977 6
1978 5
1979 15
1980 12
1981 20
1982 19
1983 27
1984 26
1985 27
1986 26
1987 22
1988 28
1989 27
1990 34
1991 31
1992 28
1993 30
1994 28
1995 35
1996 41
1997 47
1998 48
1999 47
2000 59
2001 36
2002 51
2003 52
2004 70
2005 55
2006 58
2007 65
2008 60
2009 73
2010 92
2011 99
2012 108
2013 109
2014 128
2015 108
2016 106
2017 131
2018 124
2019 143
2020 135
2021 166
2022 164
2023 134
2024 109
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,860 results

Results by year

Filters applied: . Clear all
Page 1
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study.
Doi T, Shitara K, Naito Y, Shimomura A, Fujiwara Y, Yonemori K, Shimizu C, Shimoi T, Kuboki Y, Matsubara N, Kitano A, Jikoh T, Lee C, Fujisaki Y, Ogitani Y, Yver A, Tamura K. Doi T, et al. Among authors: naito y. Lancet Oncol. 2017 Nov;18(11):1512-1522. doi: 10.1016/S1470-2045(17)30604-6. Epub 2017 Oct 13. Lancet Oncol. 2017. PMID: 29037983 Clinical Trial.
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study.
Li BT, Meric-Bernstam F, Bardia A, Naito Y, Siena S, Aftimos P, Anderson I, Curigliano G, de Miguel M, Kalra M, Oh DY, Park JO, Postel-Vinay S, Rha SY, Satoh T, Spanggaard I, Michelini F, Smith A, Machado KK, Saura C; DESTINY-PanTumor01 study group. Li BT, et al. Among authors: naito y. Lancet Oncol. 2024 Jun;25(6):707-719. doi: 10.1016/S1470-2045(24)00140-2. Epub 2024 May 3. Lancet Oncol. 2024. PMID: 38710187 Clinical Trial.
Iron and cardiovascular diseases.
Naito Y, Masuyama T, Ishihara M. Naito Y, et al. J Cardiol. 2021 Feb;77(2):160-165. doi: 10.1016/j.jjcc.2020.07.009. Epub 2020 Jul 30. J Cardiol. 2021. PMID: 32739111 Free article. Review.
Drebrin and Spine Formation.
Takahashi H, Naito Y. Takahashi H, et al. Among authors: naito y. Adv Exp Med Biol. 2017;1006:157-181. doi: 10.1007/978-4-431-56550-5_10. Adv Exp Med Biol. 2017. PMID: 28865020 Review.
Preliminary results from ASCENT-J02: a phase 1/2 study of sacituzumab govitecan in Japanese patients with advanced solid tumors.
Naito Y, Nakamura S, Kawaguchi-Sakita N, Ishida T, Nakayama T, Yamamoto Y, Masuda N, Matsumoto K, Kogawa T, Sudo K, Shimomura A, Lai C, Zhang D, Iwahori Y, Gary D, Huynh D, Iwata H. Naito Y, et al. Int J Clin Oncol. 2024 Nov;29(11):1684-1695. doi: 10.1007/s10147-024-02589-x. Epub 2024 Sep 20. Int J Clin Oncol. 2024. PMID: 39302614 Free PMC article. Clinical Trial.
Precision medicine in breast cancer.
Naito Y, Urasaki T. Naito Y, et al. Chin Clin Oncol. 2018 Jun;7(3):29. doi: 10.21037/cco.2018.06.04. Chin Clin Oncol. 2018. PMID: 30056731 Free article. Review.
Tissue engineering in the vasculature.
Naito Y, Rocco K, Kurobe H, Maxfield M, Breuer C, Shinoka T. Naito Y, et al. Anat Rec (Hoboken). 2014 Jan;297(1):83-97. doi: 10.1002/ar.22838. Epub 2013 Dec 2. Anat Rec (Hoboken). 2014. PMID: 24293111 Free article. Review.
Heme oxygenase-1 and anti-inflammatory M2 macrophages.
Naito Y, Takagi T, Higashimura Y. Naito Y, et al. Arch Biochem Biophys. 2014 Dec 15;564:83-8. doi: 10.1016/j.abb.2014.09.005. Epub 2014 Sep 18. Arch Biochem Biophys. 2014. PMID: 25241054 Review.
2,860 results